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Structure of the Homer EVH1 Domain-Peptide Complex
Reveals a New Twist in Polyproline Recognition
the Wiskott-Aldrich Syndrome protein (WASP) and its
neuronal homolog, N-WASP (Derry et al., 1994; Miki et
al., 1996; Symons et al., 1996; Figures 1A and 1B). Homer
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EVH1 domains are highly conserved and bind a proline-*Department of Biophysics and Biophysical Chemistry
rich ªHomer ligandº motif present in mGluRs, IP3Rs,²Department of Neuroscience
ryanodine receptors (RyRs), and Shank proteins (Tu et³Howard Hughes Medical Institute
al., 1998, 1999; Naisbitt et al., 1999; Figure 1C). TheJohns Hopkins University School of Medicine
original IEG form of Homer, termed Homer 1a, includesBaltimore, Maryland 21205
only 11 additional residues after the N-terminal EVH1
domain, while all other Homer proteins possess an ex-
tended C-terminal region of variable length predictedSummary
to adopt a coiled-coil (CC) structure. The CC region
mediates homophilic and heterophilic interactionsHomer EVH1 (Ena/VASP Homology 1) domains interact
within the Homer family (Kato et al., 1998; Sun et al.,with proline-rich motifs in the cytoplasmic regions of
1998; Xiao et al., 1998; Tadokoro et al., 1999). All knowngroup 1 metabotropic glutamate receptors (mGluRs),
functional properties of Homer proteins can be rational-inositol-1,4,5-trisphosphate receptors (IP3Rs), and
ized by the binding characteristics of the EVH1 and CCShank proteins. We have determined the crystal struc-
domains (Tu et al., 1998; Xiao et al., 1998).ture of the Homer EVH1 domain complexed with a
EVH1 domains in other proteins also interact with poly-peptide from mGluR (TPPSPF). In contrast to other
proline-containing target sequences. The EVH1 do-EVH1 domains, the bound mGluR ligand assumes an
mains of Ena and VASP recognize polyproline motifs inunusual conformation in which the side chains of the
zyxin, vinculin, and the Listeria monocytogenes ActASer±Pro tandem are oriented away from the Homer
protein (Niebuhr et al., 1997; Purich and Southwick,surface, and the Phe forms a unique contact. This
1997). Interactions with zyxin and vinculin are essentialunusual binding mode rationalizes conserved features
for the proper function of Ena and VASP, which are foundof both Homer and Homer ligands that are not shared
at sites of dynamic actin assembly and are thought toby other EVH1 domains. Site-directed mutagenesis
play an important role in the signal-induced reorganiza-confirms the importance of specific Homer residues
tion of microfilaments (Reinhard et al., 1992, 1995; Brin-for ligand binding. These results establish a molecular
dle et al., 1996; Gertler et al., 1996; Ahern-Djamali et al.,basis for understanding the biological properties of
1998; Lanier et al., 1999; Wills et al., 1999). Ena/VASPHomer-ligand complexes.
proteins have also been implicated in the actin-based
motility of various intracellular bacterial pathogens, such
Introduction as Listeria (Chakraborty et al., 1995; Gertler et al., 1996;
Smith et al., 1996; Laurent et al., 1999).
The Homer (vesl) family of proteins was initially identified The Homer ligand consensus sequence is PPxxF (Tu
in screens for proteins whose expression is upregulated et al 1998; Figure 1C). Single amino acid substitutions
in neurons following synaptic activity (Brakeman et al., at the proline or phenylalanine positions disrupt Homer
1997; Kato et al., 1997). Genes with this expression pat- binding to short peptides or full-length mGluRs (Tu et
tern, termed immediate-early genes (IEG), have gener- al., 1998) or Shank proteins (Tu et al., 1999). This ligand
ated interest as potential mediators of synaptic plasticity specificity contrasts with that of Ena and VASP, which
and thus learning and memory (Goelet et al., 1986). To bind the sequence FPPPP (Niebuhr et al., 1997). Re-
date, one Drosophila and three mammalian Homer cently, crystal structures of the Mena (a murine Ena
genes have been identified (Kato et al., 1998; Sun et al., homolog) and EVL (Ena/VASP-Like) EVH1 domains com-
1998; Xiao et al., 1998). The mammalian Homer proteins plexed with proline-rich ligands have been determined
localize to the postsynaptic density (PSD), where they (Fedorov et al., 1999; Prehoda et al., 1999). These struc-
appear to function as adaptor proteins that bind and tures reveal the FPPPP sequence bound in virtually iden-
cross-link cytoplasmic regions of group 1 metabotropic tical fashion with the ligand forming a type II polyproline
glutamate receptors (mGluRs), inositol-1,4,5-trisphos- (PPII) helix (Figure 4A). Recognition of proline-rich li-
phate receptors (IP3Rs), and the recently discovered gands in PPII helical conformation is a feature of many
Shank proteins (Brakeman et al., 1997; Kato et al., 1998; protein±protein interactions, including those mediated
Tu et al., 1998, 1999; Naisbitt et al., 1999). by profilin, SH3, and WW domains (Musacchio et al.,
The N-terminal z110 amino acids of all Homer pro- 1994; Yu et al., 1994; Macias et al., 1996; Mahoney et
teins show homology to EVH1/WH1 (Ena/VASP homol- al., 1999). An interesting feature of the PPII helices is
ogy 1/Wiskott-Aldrich syndrome protein homology 1) that they superimpose reasonably well when oriented
domains found in the Ena/vasodilator-stimulated phos- either from N to C or C to N terminus, and both profilin
phoprotein (VASP) protein family (Gertler et al., 1996; and SH3 domains have been shown to bind ligands in
Kato et al., 1997; Ponting and Phillips, 1997) as well as both forward and reverse orientations (Feng et al., 1994;
Mahoney et al., 1999). The presence of a conserved Phe
in the Homer ligand on the opposite side of conserved§ To whom correspondence should be addressed (e-mail: leahy@
groucho.med.jhmi.edu). prolines relative to the Ena/VASP ligands suggested that
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Figure 1. EVH1 Domains and Homer Ligand Sequences
(A) EVH1 domains are found at or near the N termini of Homer, Ena, Mena, VASP, and WASP proteins. Homer 1b/2/3 possess a C-terminal
coiled-coil (CC) domain that mediates multimerization between various Homer proteins. The EVH1 domain in Ena, Mena, VASP, WASP, and
N-WASP is followed by a central proline-rich region of variable length that contains docking sites for profilin (ABM-2 repeats) and SH3 domains
(Purich and Southwick, 1997; Ramesh et al., 1999). The EVH2 regions mediate the multimerization of Ena, Mena, and VASP proteins (Ahern-
Djamali et al., 1998). The G protein binding domain (GBD) of WASP and N-WASP interacts with the small G protein Cdc42 (AspenstroÈ m et al.,
1996). The C-terminal verprolin homology domain (VPH) of N-WASP is necessary and sufficient for actin binding (Miki and Takenawa, 1998).
The proteins are drawn to the scale shown, and the respective amino acid lengths are shown at the right.
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Homer might bind ligand in an orientation opposite to and all subsequent analyses reported here refer to the
coordinates of the Homer-peptide complex. Superposi-that observed for Mena and EVL.
To elucidate the molecular nature of interactions be- tion of the Homer, Mena, and EVL EVH1 domains reveals
no significant topological differences. Eighty-five coretween Homer and its ligands, we have determined the
crystal structure of the rat Homer 1 EVH1 domain both a carbon atoms superimpose with an overall rmsd of
1.49 AÊ between Homer and Mena, 1.54 AÊ between Homeralone and complexed with an mGluR-derived peptide.
These structures reveal that the Homer EVH1 domain and EVL, and 0.71 AÊ between Mena and EVL.
EVH1 domains are structurally homologous to plecks-binds ligand in a unique manner that distinguishes it
from other EVH1 domains and indeed from other PPII- trin homology (PH) and phosphotyrosine-binding (PTB)
domains, but PH and PTB domains bind ligands at sitesbinding proteins. The distinctive mode of Homer ligand
binding minimizes the potential for cross-reaction with unrelated to the EVH1 ligand binding site (Macias et al.,
1994; Yoon et al., 1994; Zhou et al., 1995; Fedorov etthe many available proline-rich target sequences. Several
residues of Homer are identified as key determinants of al., 1999; Prehoda et al., 1999). Although PH domains
exhibit very low levels of sequence conservation (,20%substrate specificity, and site-directed mutagenesis con-
firms their role in ligand recognition. Unexpectedly, sev- identity between family members), all PH domain struc-
tures are characterized by a highly polarized distributioneral Homer mutants selectively bind mGluR versus Shank,
indicating ligand-specific features of Homer-mediated of surface charge (Ferguson et al., 1994; Macias et al.,
1994) that is believed to facilitate interactions with posi-interactions.
tively charged lipid membranes (reviewed in Lemmon
and Ferguson, 1998). Unlike PH domains, the HomerResults
EVH1 domain shows no concentrated regions of positive
charge and does not bind 3H-IP3 in a centrifugationStructure of the Homer EVH1 Domain
A fragment of rat Homer 1 encompassing residues 1±120 binding assay (data not shown).
Despite unequivocal structure similarity, no detect-was expressed in E. coli, purified to homogeneity, and
crystallized. The structure was determined to 1.7 AÊ lim- able sequence similarity exists between EVH1 domains
and either PH or PTB domains, even when iteratediting resolution utilizing multiwavelength anomalous dif-
fraction (MAD) data collected from a single crystal of search strategies such as PSI-BLAST (Altschul et al.,
1997) are employed (Figure 1B). Overall, 12 out of 49selenomethionyl-substituted (SeMet) protein. Only resi-
dues 1±111 were observed in this structure, and this structurally homologous residues shared by EVH1, PH,
and PTB domains occur at buried sites. This pattern ofshorter fragment of rat Homer 1 was expressed and
cocrystallized with a synthetic peptide derived from buried residues is especially conserved in b7 and aC
(residues 86±103 in Homer 1) and allowed identificationmGluR (NH2-TPPSPF-CONH2). Diffraction data to 1.9 AÊ
limiting resolution were collected from a single ortho- of a previously undetected EVH1 domain at the N termi-
nus of the Drosophila protein Still Life (SIF) using a PHI-rhombic crystal of the Homer-ligand complex, and the
structure was solved by molecular replacement using BLAST search (Zhang et al., 1998; Figure 1B). SIF is a
2064 amino acid protein found adjacent to the plasmathe structure of the uncomplexed Homer EVH1 domain
as a search model. The molecular replacement solution membrane of synaptic terminals that interacts with Rho-
like GTPases and participates in the organization ofwas used to calculate a Fo-Fc difference electron density
map that revealed unambiguous density for all six resi- the actin cytoskeleton (Sone et al., 1997). Identification
of an EVH1 domain in SIF suggests that this regiondues of the bound peptide (Figure 3A). Data collection,
phasing, and refinement statistics are shown in Table may mediate interactions with a polyproline-containing
ligand.1, along with stereochemical parameters of the final
models.
A ribbon diagram of the Homer EVH1 domain with the Comparison of Homer and Mena/EVL
Peptide Bindingbound peptide is shown in Figure 2A. No significant
differences are observed between the structure of the As shown in Figure 4A, the Mena and EVL EVH1 domains
bind the core peptide FPPPP in an essentially identicalEVH1 domain with and without bound peptide (104 a
carbon atoms superimpose with an rmsd of 0.64 AÊ ), PPII conformation within a homologous binding cleft.
(B) Sequence alignment of EVH1 domains. Species are indicated by Rn (rat), Hs (human), Mm (mouse), and Dm (Drosophila). Secondary
structure elements of the Homer EVH1 domain are represented by arrows (b strands), cylinders (a helices), and lines (coils). Residues involved
in ligand contacts are colored according to conservation among EVH1 domains: residues absolutely conserved between Homer and Mena/
EVL sequences are highlighted in yellow, those conserved only among Homer sequences are colored blue, and those conserved only among
Mena/EVL sequences only are colored pink. The Homer and Mena/EVL EVH1 domains have an overall sequence identity of z30%, while the
Mena and EVL EVH1 domains are 71% identical. The fractional solvent accessibility (FSA) of each residue in Homer 1a is indicated by ovals.
Filled ovals 5 0 # FSA # 0.1 (buried); shaded ovals 5 0.1 , FSA # 0.4 (partially accessible); open ovals 5 FSA . 0.4 (exposed). Missense
mutations found in the EVH1 domain of the WASP gene are indicated in lower case letters below the WASP amino acid sequence. Mutations
that are associated with the severe (classic) WAS phenotype are shown in bold letters (Zhu et al., 1997). Sites mutated to more than one
residue are indicated by asterisks (S82P/F, R86C/H/P/L, Y107S/C, and A134T/V). Bold asterisks indicate residues that, when mutated, affect
the interaction of WASP with WIP (Stewart et al., 1999). Gaps are indicated by dashes while continued sequences at N-and C-termini are
indicated by periods. Residue numbering for Homer 1a is shown above its amino acid sequence. The number of the last included residue of
each protein is shown at the end of each row.
(C) Alignment of Homer EVH1 ligand sequences from mGluR, IP3R, RyR, and Shank proteins, highlighting the residues absolutely required
for recognition that define the consensus Homer ligand motif PPxxF (Tu et al., 1998, 1999).
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Table 1. Data Collection, Phase Calculation, and Refinement Statistics
SeMet Homer EVH1 (MAD Data) EVH1 1 Peptide
Resolution limits (AÊ ) 30.0±1.7 30.0±1.9
Wavelength (AÊ ) 0.9879 0.9793 0.9790 0.9611 1.5418
Unique reflections 24051 24179 24226 24479 7996
Redundancy 4.8 4.8 4.8 4.9 7.3
Completeness (%) 96.8 97.2 97.3 98.4 98.3
(,I./,sI.)a 21.5 (2.3) 21.0 (2.1) 20.9 (2.0) 20.4 (1.9) 28.0 (5.1)
Rsym (%)a 8.1 8.7 9.1 8.8 8.8
Overall figure of merit 0.71
Correlation coefficientb 41.7
R (%)b 46.5
MAD Structure Factor Ratiosc and Anomalous Scattering Factorsd
Wavelength (AÊ ) 0.9879 0.9793 0.9790 0.9611
0.9879 0.033 0.040 0.032 0.026
0.9793 0.047 0.029 0.044
0.9790 0.063 0.036
0.9611 0.050
f9 (e) 24.87 29.96 28.06 24.15
f† (e) 0.47 3.77 6.28 4.12
Refinement Statisticse Homer EVH1 EVH1 1 Peptide
Resolution limits (AÊ ) 30.0±1.7 30.0±1.9
Rcryst (%) 24.5 24.1
Rfree (%) 28.5 28.9
Average B (AÊ 2) protein 19.0 24.7
solvent 39.1 44.3
peptide Ð 25.9
No. of water molecules 88 76
Rmsd bond lengths (AÊ ) 0.0126 0.0187
Rmsd bond angles (8) 1.745 1.924
Rmsd B values (AÊ 2)
bonds/angles main chain 1.739/2.560 1.611/2.296
bonds/angles side chains 2.553/3.659 2.402/3.308
a Values in parentheses are for the highest resolution shell. Rsym 5 100 3 SjI 2 ,I.j/SI, where I is the integrated intensity of a given reflection
summed over the entire unit cell.
b R value 5 SjFp(obs) 2 Fp(calc) j/SFp(obs), where Fp is the structure factor amplitude.
c RMS (DjFj)/RMS (jFj), where DjFj is the Bijvoet difference at one wavelength (values on the diagonal) or the dispersive differences between
two wavelengths (values off the diagonal).
d Anomalous components of the Se scattering factors as a function of wavelength as determined by SOLVE (Terwilliger and Eisenberg, 1983).
e Final rounds of refinement included all data. The free R value was calculated from 10% of the data excluded from the refinement (BruÈ nger,
1992a).
Superposition of the a carbon positions of eight ligand- equivalent atoms. In contrast, the ligand bound to Homer
(TPPSPF) occupies a partially overlapping but dis-contacting residues of Mena and EVL results in the su-
perposition of the bound ligand atoms with an rmsd of tinct binding site (Figure 4B). While the Homer and Mena/
EVL ligands are bound in the same orientation, they0.72 AÊ for all equivalent atoms, and superposition of the
bound ligands alone results in an rmsd of 0.51 AÊ for all overlap only in a pair of tandem prolines (Pro-2/Pro-3
Figure 2. Structural Comparison of Homer
and Mena EVH1 Domains
Ribbon diagrams of the (A) Homer and (B)
Mena EVH1 domains (Prehoda et al., 1999)
with bound ligands shown in red. Both mole-
cules are shown in a similar orientation. This
figure, as well as Figure 3B, was prepared
using MOLSCRIPT (Kraulis, 1991).
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Figure 3. Structure and Environment of the Homer Ligand
(A) Fo-Fc difference electron density map calculated at 1.9 AÊ resolution using coefficients calculated from the initial molecular replacement
solution, contoured at 1.7s and superimposed with the final model for the bound ligand TPPSPF. This figure was prepared using SETOR.
(B) Stereo diagram of the Homer ligand binding site showing protein residues (yellow) with side chains within 3.85 AÊ of the bound ligand
(blue). The conserved proline residues of the ligand (Pro-2 and Pro-3) adopt a PPII conformation. Ser-4, Pro-5, and Phe-6 form a type VIa
beta turn, positioning the conserved phenylalanine on the same face of the ligand as the conserved proline residues. This face of the ligand
interacts with the protein while the side chains of the nonconserved Ser-4 and Pro-5 are exposed to solvent. When calculated in the absence
and presence of the Homer protein, the fractional solvent accessibilities of Pro-2, Pro-3, and Phe-6 decrease from 0.61, 0.85, and 0.70 to
0.17, 0.13, and 0.16, respectively, while the fractional solvent accessibilities of Ser-4 and Pro-5 remain unchanged at 1.0 and 0.83, respectively.
of the Homer ligand and Pro-4/Pro-5 of the Mena/EVL Homer sequences, but bulkier amino acids are found at
this position in all non-Homer EVH1 domains (Figure 1B).ligand). Unique features of EVH1 domain±ligand interac-
tions that differentiate the Homer and Mena/EVL sub-
families are found on opposite sides of these prolines. Mutagenesis of Homer Binding Site Residues
To determine the importance of specific residues forThe N-terminal threonine of the bound Homer peptide
does not directly contact the protein, and the amino ligand binding, several Homer EVH1 point mutants were
constructed and assayed for ligand binding (Figure 5).acid at this position is highly variable among Homer
ligand sequences (Figure 1C). Thr-1, Pro-2, Pro-3, and To test whether a glycine at position 89 is required to
accommodate the ligand phenylalanine, Gly-89 was mu-Ser-4 of the bound Homer peptide adopt the PPII confor-
mation, but Ser-4 also occupies the second position of tated to either alanine or asparagine. Ena/VASP, as well
as most other EVH1 domain proteins, naturally possessa type VIa beta turn comprising residues Pro-3, Ser-4,
Pro-5, and Phe-6 (Figure 3). Type VIa beta turns require asparagine at this position. Substitution of either alanine
or asparagine eliminated detectable binding of Homera cis-proline at the third position, and this feature is
observed in the bound Homer ligand. The tight turn EVH1 to both mGluR1 and Shank 3, thus identifying Gly-
89 as a key determinant of Homer ligand specificity.positions the side chains of Ser-4 and Pro-5 away from
the protein surface and exposes them to solvent. These To examine the relevance of proline interactions, three
of the four critical proline contact sites in Homer wereresidues occupy positions in the ligand that are highly
divergent between different Homer targets (Figure 1C). mutated (Trp-24, Thr-70, and Phe-74, but not Phe-14).
Mutation of Phe-74 and Trp-24 to alanine disruptedFor example, the amino acids at these positions are
Lys±Lys in IP3Rs and Leu±Glu or Glu±Glu in Shanks. binding to both Shank 3 and mGluR1. In contrast, muta-
tion of Trp-24 to tyrosine selectively disrupted bindingFailure to conserve a proline at position 5 in Homer
target sequences indicates that a type VIa tight turn is to mGluR1 but not to Shank 3. Mutation of Thr-70 to
glutamic acid disrupted binding to Shank 3 but not tonot a specific structural requirement for bound Homer
ligands. It is likely, however, that a tight turn is required mGluR1, while mutation of Thr-70 to alanine did not
affect binding to either ligand. The target selectivity offor appropriate positioning of the conserved phenylala-
nine and proline residues. the W24Y and T70E mutations suggests a role for ligand-
specific features in Homer-mediated interactions. TheThe conserved Phe-6 at the C terminus of the bound
Homer ligand is substantially buried between the Homer failure of the T70A mutation to disrupt ligand binding
may reflect that, in contrast to the T70E mutation, re-protein and the residues of the peptide tight turn (Figures
3B and 4B). The side chain of Phe-6 directly abuts the placement of a larger amino acid with a smaller amino
acid is potentially less deleterious than vice versa anda carbon position of Gly-89 in the Homer protein (Figure
3B), and any models that substitute residues other than results in an effect on ligand binding that is too small
to be detected by our assay.glycine at this position generate substantial steric
clashes. Glycine is conserved at this position in all In the Mena and EVL EVH1 domain structures, the
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Figure 4. Structural Comparison of Homer and Mena/EVL Peptide Binding
(A) Surface representation of the Mena EVH1 domain with bound Mena (red) and EVL (green) ligands shown as a stick representation. Only
the core FPPPP residues of the bound EVL ligand are shown for ease of comparison with the bound Mena ligand. The orientation of the EVH1
domain in both panels is identical to that in Figures 2 and 5B.
(B) Surface representation of the Homer EVH1 domain with the bound Homer peptide shown in blue. The Mena ligand is shown in red in its
relative position on the Homer surface. Residues involved in ligand contacts are colored according to conservation among EVH1 domains:
residues absolutely conserved between Homer and Mena/EVL sequences are highlighted in yellow (Trp-24 and Phe-74), those conserved only
among Homer sequences are colored blue (His-12, Phe-14, Thr-70, and Gly-89), and those conserved only among Mena/EVL sequences are
colored pink (Ile-16, Thr-66, Thr-68, Gln-76, Ala-78, and Val-85). Residues highlighted in this figure are also indicated with the same color
scheme in Figure 1B. This figure, as well as Figures 5B and 6, was prepared using GRASP (Nicholls et al., 1991).
conserved ligand phenylalanine makes contacts with complexed with the mGluR-derived peptide TPPSPF.
These structures reveal peptide bound to the HomerLys-69, Gln-79, Asn-71, Arg-81, and Val-86 (Mena num-
bering). The equivalent residues in Homer do not make domain in a different manner than has been observed
for the Mena and EVL EVH1 domains (Fedorov et al.,ligand contacts, and only two are preserved: Gln-76
(equivalent to Gln-79 in Mena) and Val-85 (Val 86 in 1999; Prehoda et al., 1999). Distinctive regions of the
Homer and Mena/EVL domains make ligand contacts,Mena). Mutation of Gln-76 to alanine or arginine did not
alter Homer ligand binding, while mutation of Val-85 to and the Homer ligand, unlike the Mena/EVL ligands,
does not adopt the PPII conformation throughout itsalanine diminished Homer binding to mGluR1, but not
to Shank 3. The effects of the V85A mutation on Homer length. Instead, the Homer ligand possesses a tight
beta turn between key protein-contacting residues. Thebinding to mGluR1 may be indirect, as Val-85 directly
contacts Trp-24, a key ligand contact residue. Homer and Mena/EVL EVH1 domains do, however,
share a homologous region that interacts with tandemThe surface locations of the residues mutated in the
Homer EVH1 domain are shown in Figure 5B. With the prolines. These results, combined with mutagenesis
studies, explain different target specificities amongexception of V85A, all mutations that affect Homer ligand
binding make direct van der Waals contacts with the EVH1 domains and identify residues important for dis-
criminating modes of substrate binding.bound peptide (see also Figure 3B). Prior to solving the
structure of the Homer EVH1-ligand complex, we tested Conservation of sequence, structure, and polyproline
recognition between the Homer and Mena/EVL EVH1a series of Homer point mutations based on reported
mutations of the WASP EVH1 domain that produce se- domains strongly suggests that these domains are de-
rived from an ancestral polyproline-binding protein. Poly-vere phenotypes (Figures 1B and 6). A number of sol-
vent-exposed hydrophobic residues were also selected proline sequences possess unique structural features
that appear to favor their selection as binding targets.as mutagenesis targets. Mutations that did not affect
binding include: F7R, S8L, N23A, S28A, S35V, D39E, The covalent bond between the proline side chain and
main chain greatly reduces the main chain torsional con-R42A, R42E, R46A, I48A, N64G, F69A, Q72A, E93K,
H95A, and L96S (data not shown). formations available to proline and strongly favors the
PPII helical conformation, which is observed for polypro-
line in solution (Kurtz et al., 1956; Stapley and Creamer,Discussion
1999). Binding of a preformed structure to a protein
results in a substantially smaller loss of configurationalWe have determined the high-resolution crystal struc-
tures of the rat Homer 1 EVH1 domain both alone and entropy upon binding than would occur for a random
Homer EVH1 Domain-Peptide Structure
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Figure 5. Homer Site-Directed Mutagenesis
(A) Immunoblot probed with pan-Homer 1 an-
tibody showing mutants of Homer 1 EVH1
domains (H1 EVH1) and full-length Homer 1c
(H1c) offered (iii) and bound to immobilized
GST-Shank 3 (i) or GST-mGluR1a (ii). All mu-
tants expressed at normal levels. Q76R,
Q76A, and T70A exhibit normal binding, while
V85A, W24A, W24Y, T70E, F74A, G89A, and
G89N disrupt detectable binding to either or
both ligands. Positive control experiments
with wild-type proteins are indicated.
(B) Surface representation of the Homer EVH1
domain showing the location of residues tar-
geted by site directed mutagenesis. Muta-
tions that disrupt binding of Homer EVH1 to
either of two ligands (GST-mGluR1a or GST-
Shank 3) are shown in red, while those that
have no effect on binding are shown in light
blue. The Homer ligand is shown in dark blue.
peptide and thus requires fewer specific interactions to sequences is reflected in the fact that profilin, EVH1,
SH3, and WW domains have all been shown to bindcompensate for the entropic cost of binding (Petrella
et al., 1996). The utility of this property of proline-rich peptides in the PPII conformation, despite otherwise
Figure 6. Mapping of WAS-Causing Mutations on the EVH1 Surface
(A and B) Surface representations of the Homer 1 EVH1 domain with sites homologous to positions of WASP mutations (in parentheses)
colored according to solvent accessibility. Solvent exposed residues are shown in magenta, and buried or partially buried residues are shown
in blue. Mutations of residues R86, Y107, and A134 have been shown to disrupt the interaction of WASP with WIP (Stewart et al., 1999). The
sites and nature of WASP mutations (Schwartz et al., 1996), the alignment of these mutations with the Homer sequence, and their solvent
exposure within the Homer EVH1 domain are indicated in Figure 1B. The orientation of the EVH1 domain in (A) is identical to that in Figure
2A. In (B), the molecule is rotated z1808 about the vertical axis.
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unrelated structures (Musacchio et al., 1994; Yu et al., suggests any other residue at this site would interfere
1994; Macias et al., 1996; Fedorov et al., 1999; Mahoney with this interaction (Figure 3B), and mutation of this
et al., 1999; Prehoda et al., 1999). The 2-fold pseudosym- residue to either alanine or asparagine eliminates de-
metry of PPII helices also has implications for interac- tectable binding of Homer to its substrates (Figure 5A).
tions with proteins in that a binding site selected to The absence of an unusual ` angle at Gly-89 suggests
recognize PPII helices may in some instances bind tar- that nonglycine residues at this position would not re-
get peptides in either orientation. Profilin and SH3 do- quire major changes in backbone conformations. All non-
mains, for example, have been shown to bind different Homer EVH1 domains possess an amino acid other than
proline-rich sequences in opposite orientations, with the glycine at this position (typically asparagine, see Figure
polarity of the bound peptide determined by nonproline 1B), indicating that these domains are unlikely to bind
residues (Feng et al., 1994; Mahoney et al., 1999; re- peptide in the same manner as Homer and that a nongly-
viewed in Kuriyan and Cowburn, 1997). cine residue at this position may be conserved in part
Given these features of proline-rich sequences, two to avoid cross-reaction with Homer substrates. Con-
aspects of the interaction between Homer and the versely, amino acid differences in Homer residues not
mGluR1 peptide are notable. First, unlike all other exam- involved in ligand contacts but equivalent to positions
ples of recognition of proline-rich targets, the mGluR1 of Mena/EVL ligand contact residues (Ile-16/Tyr-16, Thr-
peptide does not adopt the PPII conformation through- 66/Lys-69, Thr-68/Asn-71, and Ala-78/Arg-81 [Homer/
out its length but rather incorporates a tight beta turn Mena numbering]) may have been selected to prevent
at its C terminus. This tight turn appears necessary for cross-reaction with Mena/EVL substrates.
the appropriate positioning of the conserved prolines Another residue with potential to discriminate be-
and phenylalanine of the ligand with the Homer domain tween Homer and Mena/EVL binding modes is Thr-70
(Figures 3B and 4B) and is thus likely to be a feature of (Homer numbering). As shown in Figure 4B, the ligand
all Homer±ligand interactions. Second, by analogy with prolines that bind to homologous sites in the Homer and
profilin and SH3 domains, the placement of a conserved Mena/EVL proteins (Pro-2 and Pro-3 in the Homer ligand
phenylalanine before prolines in Mena/EVL targets and and Pro-4 and Pro-5 in the Mena/EVL ligands) are shifted
after prolines in Homer targets suggested that Homer by z2 AÊ relative to one another following superposition
EVH1 domains might bind ligands at a site homologous of the Homer and Mena EVH1 domains. This shift ap-
to the Mena/EVL binding site but with the main chain pears to be due in part to Thr-70 in the Homer protein,
oriented in the opposite direction. However, the Homer which contacts Pro-2 of the Homer ligand but would
EVH1 domain interacts with the mGluR1 peptide in the clash with a peptide bound in the Mena/EVL-like posi-
same orientation as that observed for the Mena/EVL tion. Thr-70 is conserved in all Homer proteins, while
EVH1 domains. While both domains use a shared region the residue at the homologous position in the Mena/
for interactions with prolines, unique sites within these EVL subfamily of EVH1 domains is alanine, which ac-
domains are utilized for crucial interactions with nonpro- commodates the relative shift of the bound peptides.
line residues. Mutation of Thr-70 to alanine in Homer does not disrupt
The use of distinct but overlapping binding sites poses ligand binding (see Figure 5A) but may be conserved in
unique challenges to the generation and maintenance Homer EVH1 domains in part to prevent interactions
of substrate specificity. Not only must key ligand contact with Mena/EVL substrates.
residues be conserved, but residues in regions that con- Our studies identified Homer mutants that selectively
tact ligand in Homer but not in Mena/EVL must be se- bind mGluRs or Shank. When Trp-24 is mutated to tyro-
lected against in Mena/EVL to avoid cross-reaction with sine, the resulting Homer mutant binds Shank 3, but not
Homer ligands and vice versa. Comparison of the Homer mGluRs. Similarly, Homer V85A binds Shank 3 but not
and Mena/EVL peptide binding sites reveals residues mGluRs. By contrast, T70E binds mGluRs but not Shank
that are conserved among all EVH1 domains as well as
3. The selectivity of these mutants may result from slight
residues that are conserved only among subsets of
differences in either the topology or energetics of the
EVH1 domains and are strictly absent from other EVH1
contacts between Homer and the prolines of these li-domains (Figures 1B and 4B). Residues that contact the
gands. These examples indicate that in addition to theligand in the overlapping region of the Homer and Mena/
core consensus residues there are determinants ofEVL ligand binding sites are conserved in all EVH1 do-
Homer binding that are ligand specific.mains and include Trp-24 and Phe-74 (following a Homer
Residues conserved only in subsets of Homer ligandsnumbering convention). Conversely, residues contact-
may also be instructive. The amino acids at positionsing the unique N-terminal regions of the Mena/EVL li-
xx of the PPxxF Homer ligand motif exhibit extremegands (Tyr-16, Lys-69, Asn-71, Gln-79, Arg-81, and Val-
variability between different families of receptors (Figure86 [Mena numbering]) are conserved in Mena and EVL,
1C). In screens of random peptide libraries, amino acidswhile identical homologs of only Gln-79 and Val-86 are
at these positions are not conserved (P. W. et al., unpub-present in Homer proteins. Residues in Homer that con-
lished data), suggesting that they are not important fortact the unique C-terminal phenylalanine of the Homer
binding to EVH1 domains. On the other hand, residuesligand (including His-12, Phe-14, Thr-70, and Gly-89
at these positions are absolutely conserved among di-[Homer numbering]) are exclusively present in Homer
vergent members of each receptor family. For example,EVH1 domains.
Lys±Lys is found at these positions in the IP3R se-Analysis of binding properties of Homer EVH1 point
quences of nematodes, flies, frogs, rats, and humans,mutants generally confirms the importance of these criti-
suggesting that these residues may be important forcal contact sites. In particular, the phenylalanine in the
Homer ligand packs directly on Gly-89 in a manner that some additional function. One possibility is that when
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bound to Homer, these residues constitute a new bind- contributions from both protein and ligand that give rise
ing surface that mediates receptor type±specific inter- to more subtle ligand preferences within members of
actions with additional molecules. both subfamilies.
The EVH1 domain structures of Homer and Mena/EVL
Experimental Proceduresmay be used to evaluate the homologous EVH1 domain
in WASP, for which no structural information is currently
Protein Expression and Purificationavailable. The WASP EVH1 domain is the target of muta-
Residues 1±120 or 1±111 of rat Homer 1a were expressed in Esche-
tions in Wiskott-Aldrich syndrome (WAS) (Derry et al., richia coli BL21 cells as a C-terminal fusion to glutathione-S-trans-
1994) and, like Ena and VASP, appears to link extracellu- ferase (GST-1aEVH) as previously described (Tu et al., 1998). Seleno-
lar signals to cytoskeletal assembly (AspenstroÈ m et al., methionine-substituted (SeMet) GST-1aEVH was prepared by
expression in the methionine auxotrophic strain B834 (DE3) (Nova-1996; Kolluri et al., 1996; Miki et al., 1996; Symons et
gen). Five milliliters of an overnight culture grown at 378C in LBal., 1996; Miki and Takenawa, 1998). WASP expression
media supplemented with 100 mg/ml ampicillin (Sigma) were addedis restricted to hematopoietic cells, and WAS, which is
to 4 liters M9 minimal media (GIBCO±BRL) supplemented with thecharacterized by eczema, thrombocytopenia, immuno-
following: 100 mg/ml ampicillin, 0.05 mg/ml alanine, aspartic acid,
deficiency, and an increased risk of lymphoid malignan- glutamic acid, phenylalanine, glycine, histidine, isoleucine, lysine,
cies, results from defects in these cells (Nonoyama and asparagine, proline, glutamine, arginine, serine, threonine, valine,
Ochs, 1998; Ramesh et al., 1999; reviewed in Kirch- tryptophan, tyrosine, L-selenomethione, 1 mg/ml thiamine (Sigma),
2 mM MgSO4, 1% glucose, and 100 mM CaCl2. Cells were grownhausen, 1998). The molecular function of WASP involves
to an OD600 of 0.5 at which time IPTG (Calbiochem) was added todirect interactions with multiple proteins, including
a final concentration of 0.2 mM. Cells were grown for an additional 3Cdc42 (AspenstroÈ m et al., 1996; Symons et al., 1996),
hr, harvested by centrifugation, and resuspended in PBS/1% Triton.
WIP (Ramesh et al., 1997), Nck (Rivero-Lezcano et al., Pepstatin A and leupeptin (Boehringer-Mannheim) were added to a
1995), Grb2 (She et al., 1997; Zhu et al., 1997), phospholi- final concentration of 1 mg/ml, and PMSF (Life Technologies) was
pase C-g (Cory et al., 1996; Zhu et al., 1997), and several added to 0.5 mM. Cells were lysed by sonication and centrifuged
at 13,000 rpm in an SS-34 rotor to pellet cell debris. The clearedkinases (Banin et al., 1996; Bunnell et al., 1996; Cory et
lysate was added to a 5 ml glutathione-agarose (Sigma) column.al., 1996; Zhu et al., 1997). These interactions appear to
The column was washed in succession with 20 column volumes ofplay a role in cytoskeletal assembly, since the T cells
PBS/1% Triton, 20 column volumes of PBS, and 10 column volumesand platelets of WAS patients exhibit cytoskeletal ab- of cleavage buffer (50 mM Tris [pH 7.4], 150 mM NaCl, 2.5 mM CaCl2,
normalities, and disruption of these interactions is likely 50 mM 2-mercaptoethanol). All buffers were degassed. A 50% slurry
to be a feature of many, if not all, WAS-causing muta- of glutathione-agarose beads loaded with fusion protein was incu-
bated with 20 units of biotinylated Thrombin (Novagen) for 16 hr attions.
room temperature. The released cleavage product (1a-EVH) wasSurface representations of the Homer EVH1 structure
collected, and the biotinylated Thrombin was removed with strep-with the location of sites homologous to disease-caus-
tavidin-agarose beads (Novagen). 1a-EVH was further purified bying mutations in the WASP EVH1 domain highlighted in
cation-exchange chromatography using a ResourceS column (Am-
color are shown in Figure 6. Most WASP mutations map ersham-Pharmacia). Peptides corresponding to hexamer and dec-
on or near one face of the EVH1 domain, and those that amer consensus sequences from mGluR, Shank, and IP3 were syn-
do not map to this face invariably occur at sites of buried thesized on a PE Biosystems 430A peptide synthesizer using Fmoc
chemistry, purified by reverse-phase HPLC, and analyzed by massresidues. Mutations that impair binding properties of
spectrometry.proteins generally fall into two categories: those that
disrupt global structure and those whose effects are
Crystallization and Data Collectionlocalized to a specific active site or binding interface.
Crystals of native and SeMet protein alone and native protein-pep-
Mutations that result in global disruptions typically occur tide complex were grown in hanging drops by the vapor diffusion
at buried hydrophobic positions or affect residues that method (Wlodawer et al., 1975). Crystals of the unliganded protein
perform key structural roles. Such mutations often ex- were grown by mixing 1 ml of a 9 mg/ml solution of native or SeMet
1aEVH 1±120 with a 1:1 dilution of reservoir buffer (30% PEG 3350,hibit no essential relation to a protein-active site. Muta-
87 mM MgSO4, 50 mM HEPES [pH 7.3]) with distilled water andtions with local effects frequently map to surface-
equilibrating over 1 ml of reservoir buffer. All crystallization trialsexposed sites that cluster within a specific region of the
for the SeMet protein were set up under anaerobic conditions toprotein surface. The majority of surface-exposed WASP minimize potential problems due to oxidation. Crystals of the pro-
mutations are found in a location that is opposite to the tein-peptide complex were grown by mixing 1 ml of a z20 mg/ml
ligand binding site in the Homer and Mena/EVL EVH1 solution of native 1aEVH 1±111 and 1 ml of 10 mg/ml peptide with
domains (Figure 6). Moreover, several WASP mutations a 1:1 dilution of reservoir buffer (30% PEG 3350, 100 mM Sodium
Acetate, 100 mM Tris [pH 8.0]) with distilled water. We observed twowere tested in Homer and did not disrupt binding to
different crystal forms for both the native and the SeMet unligandedHomer ligands. This strongly suggests that the WASP
protein. Crystals in the orthorhombic space group P212121 (unit cellEVH1 domain interacts with ligands at different sites
dimensions: a 5 33.79 AÊ , b 5 51.40 AÊ , c 5 66.30 AÊ ) typically grew
than the Homer and Mena/EVL EVH1 domains. to a size of 0.5 mm 3 0.03 mm 3 0.03 mm. Crystals in the trigonal
The structure of the Homer EVH1 domain with bound space group P3221 (unit cell dimensions: a 5 b 5 49.94 AÊ , c 5
peptide adds a new twist to the binding modes of EVH1/ 80.91 AÊ ) grew to a size of 0.4 mm 3 0.1 mm 3 0.1 mm. Crystals
PH/PTB domains and rationalizes conserved residues of the protein-peptide complex grew in space group P21212 to a
maximum size of 0.55 mm 3 0.28 mm 3 0.01 mm. All data used forin both EVH1 domain subsets and their targets. Among
phasing and refinement of the unliganded protein were collectedEVH1 domains, Homer proteins appear to be unique in
from a single trigonal SeMet crystal soaked in mother liquor plustheir mode of ligand recognition and represent a distinct
10% (v/v) ethylene glycol for approximately 3 min prior to flash
functional subset of these domains. While the principal freezing in a gaseous nitrogen stream at 21808C. X-ray diffraction
elements of ligand binding and recognition by the Homer data suitable for multiwavelength anomalous dispersion (MAD)
and Mena/EVL subfamilies of EVH1 domains seem well phasing were collected at four wavelengths at or near the Se absorp-
tion edge. These data were collected at beamline X4A of the Nationalunderstood, future work will be needed to elucidate the
Neuron
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Synchrotron Light Source at Brookhaven National Laboratory using PBS/1% Triton X-100 (Sigma) and protease inhibitors. GST pull-
down assays were performed by mixing 100 ml of cell lysate withan R-AXIS IV image plate detector. Nonoverlapping oscillations (28)
at ` and ` 1 1808 were measured over a 908 rotation of the crystal, GST-mGluR1a (mGluR1a residues 1104±1199) and GST-Shank 3
(Shank 3 residues 1269±1408; Tu et al., 1999) bound to glutathione-interleaving the four wavelengths. Data used to solve the protein-
peptide complex were collected from a single crystal flash frozen agarose, incubating at 48C for 2 hr, and washing with PBS and
PBS/1% Triton X-100. Bound products were eluted with 100 ml 23at 21808C, using CuKa radiation generated by a Rigaku RU-200
generator and an R-AXIS IV image plate detector. Nonoverlapping SDS loading buffer and detected by SDS-PAGE and immunoblot
using pan-Homer 1 antibody and ECL reagents (Amersham).oscillations (1.58) were measured over a 2478 rotation of the crystal.
All data were processed and scaled using the DENZO/SCALEPACK
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